Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.

Pal S, Rawat L, Prakash CM, Sasamoto Y, Basu RT, Sabarwal A

Open source

DOI
10.1158/1535-7163.mct-26-0483
Published
2026 Sep 24
Container
Molecular cancer therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-26-0483,
  title = {Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.},
  author = {Pal S and Rawat L and Prakash CM and Sasamoto Y and Basu RT and Sabarwal A},
  year = {2026},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-26-0483},
  url = {https://doi.org/10.1158/1535-7163.mct-26-0483}
}

RIS

TY  - JOUR
TI  - Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.
AU  - Pal S
AU  - Rawat L
AU  - Prakash CM
AU  - Sasamoto Y
AU  - Basu RT
AU  - Sabarwal A
PY  - 2026
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-26-0483
UR  - https://doi.org/10.1158/1535-7163.mct-26-0483
ER  - 

APA

S, P., L, R., CM, P., Y, S., RT, B., & A, S. (2026). Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-26-0483

Source records